| |
|
|
|
Biocryst Pharma Inc  
|
|
5.11 -0.02 (-0%) |
11-30 16:00 |
|
Open: |
5.18 |
Pre close: |
5.13 |
Target:
|
6.17 
|
|
High: |
5.285 |
Low: |
4.825 |
Resistance:
|
5.28
6.17
|
|
Volume: |
8,409,349 |
Market Cap: |
902M |
Support:
|
4.23
3.57
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.81
|
MACD |
MACD(12,26):
|
0.27 |
|
MA(20): |
4.36 |
Signal(12,26,9): |
0.19 |
|
MA(100): |
4.12  |
Stochastic Oscillator |
%K(14,3):
|
93.61 |
|
MA(250): |
3.69 |
%D(3): |
89.94 |
|
Average Volume(K) |
3-Month: |
482575
|
52-Week |
High:
|
6.29 |
|
10-Days: |
491584 |
Low: |
1.58 |
|
RSI |
RSI(14):
|
70.99 |
Change(%): |
79.9 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.801 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
176.57 |
|
EPS Est. Current Year |
-0.750 |
Return on Assets (ttm) |
-57.4 |
Shares Float (M) |
161.20 |
|
EPS Est. Next Year |
-0.780 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.85 |
|
EPS Est. Next Quarter |
-0.180 |
Qtrly Rev. Growth |
243.8 |
% Held by Institutions |
73.87 |
|
Forward EPS |
-0.940 |
Gross Profit (p.s.) |
-0.353 |
Shares Short (K) |
41320 |
|
Book Value (p.s.) |
0.190 |
EBITDA (p.s.) |
-0.689 |
P/E |
-6.38 |
|
Sales Per Share |
0.303 |
Qtrly Earnings Growth |
0.00 |
P/BV |
26.89 |
|
Profit Margin |
-233.45 |
Operating Cash Flow
(M) |
-103.03 |
P/S |
16.86 |
|
Operating Margin |
-228.81 |
Levered Free Cash Flow
(M) |
-63.88 |
P/CF |
-8.76 |
|
|
|
|
|
|
